Print

Purpose

The study will attempt to put into practice a shared decision making (SDM) strategy, using an individualized, computerized decision- aid (DA) for Systemic lupus erythematosus (SLE).

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aim 1: clinic personnel involved in the care of lupus patients - Aim 2: clinic personnel involved in the care of lupus patients - Aim 3: clinic personnel involved in the care of lupus patients Clinic Personnel

Exclusion Criteria

  • Aim 1: none - Aim 2: none - Aim 3: none Patient Inclusion Criteria: - Aim 2: Adults with a diagnosis of lupus - Aim 3: Adults with a diagnosis of lupus Patient Exclusion Criteria: - Aim 2: No diagnosis of lupus, not English or Spanish speaking, visually impaired, altered mental status - Aim 3: No diagnosis of lupus, not English or Spanish speaking, visually impaired, altered mental status

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Other

Arm Groups

ArmDescriptionAssigned Intervention
Lupus Patients All lupus patients, regardless of if they are having an active flare
  • Other: SMILE Computerized Decision-Aid
    SMILE is a computerized decision-aid designed to give lupus patients information about lupus, treatments for lupus available to them, as well as side effects. This will be administered at every lupus clinic session. Every patient will see the SMILE Computerized Decision-Aid at their index baseline clinic visit.
    Other names:
    • SMILE
    • Decision-Aid
    • DA

More Details

Status
Active, not recruiting
Sponsor
University of Alabama at Birmingham

Study Contact

Detailed Description

The proposed study will evaluate methods to implement a shared decision making strategy, using an individualized, computerized decision- aid (DA). The investigators will test the effectiveness of this implementation with 3 strategies in 16 clinics. Formative evaluation strategies will be used to assess needs at each clinic, with key clinic informants participating in semi-structured interviews. The study will enroll at least 500 patient participants across all 16 sites, who will review the decision aid and be asked a feasibility and acceptability assessment. At the conclusion of the study, key clinic informants, as well as selected patient participants will participate in semi-structured interviews to assess the effectiveness in implementing the DA in the clinic setting.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.